Differential expression of 9-O-acetylated sialoglycoconjugates on leukemic blasts: A potential tool for long-term monitoring of children with acute lymphoblastic leukemia

International Journal of Cancer

Volumn 111, Issue 2, 2004, Pages 270-277

  Pal, Santanu ^a,c   Ghosh, Shyamasree ^a   Bandyopadhyay, Suman ^a   Mandal, Chhabinath ^a   Bandhyopadhyay, Santu ^a   Bhattacharya, Dilip Kumar ^b   Mandal, Chitra ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b VIVEKANANDA INSTITUTE OF MEDICAL SCIENCES   (India)

^c GURUDAS COLLEGE   (India)

Author keywords

9 O acetylated sialic acid binding lectin; Achatinin H; Acute lymphoblastic leukemia; Carbohydrate; Minimal residual disease; Sialic acid

Indexed keywords

9 O ACETYLGANGLIOSIDE; 9 O ACETYLSIALIC ACID; 9 O ACETYLSIALIC ACID BINDING LECTIN; 9 O ACETYLSIALOGLYCOCONJUGATE; 9 O ACETYLSIALOGLYCOCONJUGATE ANTIBODY; ACHATIN 1; ACHATININ H; ANTIBODY; LECTIN; SIALIC ACID DERIVATIVE; SIALOGLYCOPROTEIN; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; BINDING AFFINITY; BLAST CELL; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; INFANT; LEUKEMIA CELL; LEUKEMIA REMISSION; LONG TERM CARE; LONGITUDINAL STUDY; LYMPHOBLAST; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RELAPSE; SENSITIVITY AND SPECIFICITY; WESTERN BLOTTING;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOTTING, WESTERN; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION PROFILING; GLYCOCONJUGATES; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; NEOPLASM, RESIDUAL; PROGNOSIS; RECURRENCE; SIALIC ACIDS; TREATMENT OUTCOME;

EID: 3142699845     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20246     Document Type: Article

References (49)

1. Pui CH, Campana D, Evans WE. Childhood acute lymphoblastic leukemia - current status and future perspectives. Lancet Oncol 2001;2:597-607.
2. Chan KW. Acute lymphoblastic leukemia. Curr Probl Pediatr Adolesc Health Care 2002;32:40-9.
3. Fatih MU, Linda S, Nita S, Mireille S, Charles B, Harland S, Martha S, Gregory HR, Paul SG. Residual bone marrow leukemic progenitor cell burden after induction chemotherapy in pediatric patients with acute lymphoblastic leukaemia. Clin Cancer Res 2000;6:3123-30.
4. Sinha D, Chatterjee M, Mandal C. O-acetylated sialic acids - their detecfion biologic significance and alteration in diseases. Trends Genet 2000;12:17-33.
5. Mandal C, Chatterjee M, Sinha D. Investigation of 9-O-acetylated sialoglycoconjugates in childhood acute lymphoblastic leukemia. Br J Haematol 2000;110:801-12.
6. Angata T, Kerr SC, Greaves DR, Varki NM, Crocker PR, Varki A. Cloning and characterization of human Siglec-11. A recently evolved signaling that can interact with SHP-1 and SHP-2 and is expressed by tissue macrophages, including brain microglia. J Biol Chem 2002;277:24466-74.
7. Schauer R, Schmid H, Pommerencke J, Iwersen M, Kohla G. Metabolism and role of O-acetylated sialic acids. Adv Exp Med Biol 2001;491:325-42.
8. Crocker PR. Siglecs: sialic-acid-binding immunoglobulin-like lectins in cell-cell interactions and signalling. Curr Opin Struct Biol 2002;12:609-15.
9. Mandal C, Mandal C. Sialic acid binding lectins. Experientia 1990;46:433-41.
10. Cheresh DA, Reisfeld RA, Varki AP. O-Acetylation of disialoganglioside GD3 by human melanoma cells creates a unique antigenic determinant. Science 1984;225:844-6.
11. Kohla G, Stockfleth E, Schauer R. Gangliosides with O-acetylated sialic acids in tumors of neuroectodermal origin. Neurochem Res 2002;27:583-92.
12. Ravindranath MH, Paulson JC, Irie RF. Human melanoma antigen O-acetylated ganglioside GD3 is recognized by Cancer antennarius lectin. J Biol Chem 1998;263:2079-86.
13. Vater M, Kniep B, Gross HJ, Claus C, Dippold W, Schwartz-Albiez R. The 9-O-acetylated disialosyl carbohydrate sequence of CDw60 is a marker on activated human B lymphocytes. Immunol Lett 1997;59:151-7.
14. Kamerling JP, Makovitzky J, Schauer R, Vliegenthart JFG, Wember M. The nature of sialic acids in human lymphocytes. Biochim Biophys Acta 1982;714:351-5.
15. Sharma V, Chatterjee M, Mandal C, Basu D, Sen S. Rapid diagnosis of Indian visceral leishmaniasis using Achatinin-H a 9-O-acetylated sialic acid binding lectin. Am J Trop Med Hyg 1998;58:551-4.
16. Chava AK, Chatterjee M, Sundar S, Mandal C. Development of an assay for quantification of linkage-specific O-acetylated sialoglycans on erythrocytes; its application in Indian visceral leishmaniasis. J Immunol Methods 2002;270:1-10.
17. Chatterjee M, Sharma V, Sundar S, Sen S, Mandal C. Identification of antibodies directed against O-acetylated sialic acids in visceral leishmaniasis, its diagnostic and prognostic role. Glycoconj J 1998;15:1141-7.
18. Chatterjee M, Chava AK, Kohla G, Pal S, Hinderlich SJ, Kamerling JP, Vlasak R, Crocker PR, Schauer R, Schwartz-Albiez R, Mandal C. Identification and characterization of adsorbed serum sialoglycans on Leishmania donovani promastigotes. Glycobiology 2003;13:351-61.
19. Sinha D, Mandal C, Bhattacharya DK. Identification of 9-O-acetyl sialoglycoconjugates (9-O-AcSGs) as biomarkers in childhood acute lymphoblastic leukemia using a lectin, Achafinin-H, as a probe. Leukaemia 1999;13:119-25.
20. Sinha D, Mandal C, Bhattacharya DK. A novel method for prognostic evaluation of childhood acute lymphoblastic leukemia. Leukaemia 1999;13:309-12.
21. Sinha D, Mandal C, Bhattacharya DK. Development of a simple, blood based lymphoproliferation assay to assess the clinical status of patients with acute lymphoblastic leukaemia. Leukaemia Res 1999;23:433-9.
22. Sinha D, Mandal C, Bhattacharya DK. A colorimetric assay to evaluate the chemotherapeutic response of children with acute lymphoblastic leukaemia (ALL) employing Achatinin-H: a 9-O-acetyl sialic acid binding lectin. Leuk Res 1999;23:803-9.
23. Mandal C, Sinha D, Sharma V, Bhattacharya DK. O-Acetyl sialic acid binding lectin, as a probe for detection of subtle changes on the cell surface induced during acute lymphoblastic leukaemia (ALL) and its clinical application. Ind J Biochem Biophys 1997;34:82-6.
24. Pal S, Chatterjee M, Bhattacharya DK, Bandhyopadhyay S, Mandal C. Identification and purification of cytolytic antibodies directed against O-acetylated sialic acid in childhood acute lymphoblastic leukemia. Glycobiology 2000;10:539-49.
25. Pal S, Chatterjee M, Bhattacharya DK, Bandhyopadhyay S, Mandal C, Mandal C. O-Acetyl sialic acid specific IgM in childhood acute lymphoblastic leukemia. Glycoconj J 2001;18:529-37.
26. Burns CP, Armitage JO, Frey AL, Dick FR, Jordan JE, Woolson RF. Analysis of the presenting features of adult acute leukemia: the French-American-British classification. Cancer 1981;47:2460-9.
27. Eden OB, Harrison G, Richards S, Lilleyman JS, Bailey CC, Chessells JM, Hann IM, Hill FGH, Gibson BES. Long term follow-up of the United Kingdom and Medical Research Council protocols for childhood acute lymphoblastic leukemia. Leukaemia 2000;14:2307-20.
28. Gaynon PS, Bostrom BC, Hutchinson RJ, Lange BJ, Nachman JB, Steinherz PG, Sensel MG, Lee MK, Stram DO, Sather HN. Duration of hospitalization as a measure of cost on Children's Cancer Group acute lymphoblastic leukemia studies. J Clin Oncol 2001;19:1916-25.
29. Sen G, Mandal C. The specificity of the binding site of Achatinin-H, a sialic-acid binding lectin from Achatina fulica. Carbohydr Res 1995;268:115-25.
30. Mandal C, Basu S. A unique specificity of a sialic acid binding lectin Achatinin-H from the haemolymph of Achatina fulica. Biochem Biophys Res Commun 1987;148:795-801.
31. Basu S, Mandal C, Mandal C. Chemical modification studies of a unique sialic acid binding lectin from the snail Achatina fulica. Biochem J 1988;254:195-202.
32. Mandal C, Basu S, Mandal C. Physicochemical studies on Achatinin-H, a novel sialic acid binding lectin. Biochem J 1989;257:65-71.
33. Hunter WM. In: Weir DM, ed. Handbook of experimental medicine. Oxford: Blackwell, 1978. 14.1-14.3.
34. Bishayi B, Samanta AK. Identification and characterization of specific receptor for interleukin-8 from the surface of human monocytes. Scand J Immunol 1996;43:531-6.
35. Coligan JE, Kruisbeek AM, Margulies DH, Stevanch EM, Strober W. Current protocols in immunology. vol. 1, sect. 6. 1991. Greene Publishing Associates.
36. Scatchered G. The attractions of proteins for small molecules and ions. Ann NY Acad Sci 1949;51:660-72.
37. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Statist Assoc 1956;53:457-81.
38. Coustan-Smith E, Sancho J, Behm FG, Hancock ML, Razzouk BI, Ribeiro RC, Rivera GK, Rubnitz JE, Sandlund JT, Pui CH, Campana D. Prognostic importance of measuring early clearance of leukemic cells by flow cytometry in childhood acute lymphoblastic leukemia. Blood 2002;100:52-8.
39. Reuter G, Vliegenthart JF, Wember M, Schauer R, Howard RJ. Identification of 9-O-acetyl-N-acetylneuraminic acid on the surface of BALB/c mouse erythrocytes. Biochem Biophys Res Commun 1980;94:567-72.
40. Bjorklund E, Mazur J, Soderhall S, Porwit-MacDonald A. Flow cytometric follow-up of minimal residual disease in bone marrow gives prognostic information in children with acute lymphoblastic leukemia. Leukaemia 2003;17:138-48.
41. Chen JS, Coustan-Smith E, Suzuki T, Neale GA, Mihara K, Pui CH, Campana D. Identification of novel markers for monitoring minimal residual disease in acute lymphoblastic leukemia. Blood 2001;97:2115-20.
42. Dworzak MN, Panzer-Grumayer ER. Flow cytometric detection of minimal residual disease in acute lymphoblastic leukemia. Leuk Lymphoma 2003;44:1445-55.
43. Coustan-Smith E, Sancho J, Hancock ML, Razzouk BI, Ribeiro RC, Rivera GK, Rubnitz JE, Sandlund JT, Pui CH, Campana D. Use of peripheral blood instead of bone marrow to monitor residual disease in children with acute lymphoblastic leukemia. Blood 2002;100:2399-402.
44. Campana D. Determination of minimal residual disease in leukemia patients. Br J Haematol 2003;121:823-38.
45. Butor C, Diaz S, Varki A. High level O-acetylation of sialic acids on N-linked oligosaccharides of rat liver membranes. Differential subcellular distribution of 7- and 9-O-acetyl groups and of enzymes involved in their regulation. J Biol Chem 1993;268:10197-206.
46. Shen Y, Tiralongo J, Iwersen M, Sipos B, Kalthoff H, Schauer R. Characterization of the sialate-7(9)-O-acetyltransferase from the microsomes of human colonic mucosa. Biol Chem 2002;383:307-17.
47. Varki A. Diversity in the sialic acids. Glycobiology 1992;2:25-40.
48. Chava AK, Chatterjee M, Sharma V, Sundar S, Mandal C. Differential expression of O-acetylated sialoglycoconjugates induces a variable degree of complement-mediated hemolysis in Indian leishmaniasis. J Infect Dis, 2004;189:1257-64.
49. Sjoberg ER, Powell LD, Klein A. Natural ligands of B cell adhesion molecule CD 22β can be masked by 9-O-acetylation of sialic acids. J Cell Biol 1994;126:549-62.